PHAXIAM Therapeutics SA (PHXM) Cash From Investing

Annual CFI

$40.21 M
+$40.62 M+9950.22%

December 31, 2022

Summary

Performance

1-Year Change

+9950.22%

3-Year Change

+281.05%

5-Year Change

+2082.38%

15-Year Change

+2082.38%

PHXM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$40.21 M
PHXM annual cash flow from investing activities is currently at an all-time high

3-Year Low

-$408.20 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PHXM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PHXM next annual earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Annual CFF

-$1.86 M
PHXM annual cash flow from financing activities is -$1.86 million

Annual CFO

-$33.50 M
PHXM annual cash flow from operations is -$33.50 million

Annual FCF

-$33.59 M
PHXM annual free cash flow is -$33.59 million

Annual CAPEX

-
PHXM annual capital expenditures value is unknown

Quarterly CFI

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$40.42 M
PHXM quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

$40.42 M
PHXM quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Quarterly CFF

-
PHXM quarterly cash flow from financing activities value is unknown

Quarterly CFO

-
PHXM quarterly cash flow from operations value is unknown

Quarterly FCF

-
PHXM quarterly free cash flow value is unknown

Quarterly CAPEX

-
PHXM quarterly capital expenditures value is unknown

TTM CFI

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$40.42 M
PHXM TTM cash flow from investing activities is currently at an all-time high

3-Year Low

$40.42 M
PHXM TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

TTM CFF

-
PHXM TTM cash flow from financing activities value is unknown

TTM CFO

-
PHXM TTM cash flow from operations value is unknown

TTM FCF

-
PHXM TTM free cash flow value is unknown

TTM CAPEX

-
PHXM TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PHXM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9950.2%--
3 y3 years+281.1%--
5 y5 years+2082.4%--

PHXM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-101.0%
5 y5-yearat high-155.2%
alltimeall timeat high-155.2%

PHAXIAM Therapeutics SA Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2022
$40.21 M(<-9900.0%)
-
-
Jun 2022
-
$40.42 M(<-9900.0%)
$40.42 M(<-9900.0%)
Dec 2021
-$408.20 K(-75.8%)
-
-
Jun 2021
-
-$330.20 K(-73.5%)
-$330.20 K(-98.5%)
Dec 2020
-$1.68 M(-92.4%)
-
-
Jun 2020
-
-$1.25 M(-94.2%)
-$22.73 M(-44.9%)
Dec 2019
-$22.21 M
-
-
Sep 2019
-
-$21.49 M(+8.9%)
-$41.22 M(+78.1%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$19.74 M(+478.6%)
-$23.15 M(+578.6%)
Dec 2018
-$7.62 M(+275.5%)
-
-
Sep 2018
-
-$3.41 M
-$3.41 M
Dec 2017
-$2.03 M(+2.6%)
-
-
Dec 2016
-$1.98 M(+527.1%)
-
-
Dec 2015
-$315.20 K(-43.6%)
-
-
Dec 2014
-$558.50 K(+45.7%)
-
-
Dec 2013
-$383.30 K(+2017.7%)
-
-
Dec 2012
-$18.10 K
-
-

FAQ

  • What is PHAXIAM Therapeutics SA annual cash flow from investing activities?
  • What is the all time high annual CFI for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA annual CFI year-on-year change?
  • What is the all time high quarterly CFI for PHAXIAM Therapeutics SA?
  • What is the all time high TTM CFI for PHAXIAM Therapeutics SA?

What is PHAXIAM Therapeutics SA annual cash flow from investing activities?

The current annual CFI of PHXM is $40.21 M

What is the all time high annual CFI for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high annual cash flow from investing activities is $40.21 M

What is PHAXIAM Therapeutics SA annual CFI year-on-year change?

Over the past year, PHXM annual cash flow from investing activities has changed by +$40.62 M (+9950.22%)

What is the all time high quarterly CFI for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high quarterly cash flow from investing activities is $40.42 M

What is the all time high TTM CFI for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high TTM cash flow from investing activities is $40.42 M